8086.T
Latest Trade
1,308.00JPYChange
-13.00(-0.98%)Volume
802,100Today's Range
-
1,325.0052 Week Range
-
1,547.00As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay
Previous Close | 1,321.00 |
|---|---|
Open | 1,322.00 |
Volume | 802,100 |
3M AVG Volume | 18.73 |
Today's High | 1,325.00 |
Today's Low | 1,300.00 |
52 Week High | 1,547.00 |
52 Week Low | 908.00 |
Shares Out (MIL) | 163.10 |
Market Cap (MIL) | 226,498.00 |
Forward P/E | 15.90 |
Dividend (Yield %) | 0.79 |
Nipro to issue unsecured corporate bonds worth 10 bln yen
R&I affirms Nipro's rating at "BBB+" and says stable outlook -R&I
R&I affirms Nipro's rating at "BBB+" and says stable outlook -R&I
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
Industry
Medical Equipment & Supplies
Contact Info
3-9-3, Honjo-nishi, Kita-ku
OSAKA-SHI, OSK
531-8510
Japan
+81.6.63722331
https://www.nipro.co.jp/Executive Leadership
Yoshihiko Sano
President, Representative Director
Goichi Miyazumi
Deputy Director of International Business, President of Subsidiary, Director
Yasushi Ohyama
Managing Director, Chief Director of Vascular Product Development Sales, Director of Vascular Business
Takehito Yogo
Managing Director, Chief Director of Business Planning
Kyoetsu Kobayashi
Managing Director, Director of Production Business, Manager of Odate Plant
Price To Earnings (TTM) | -- |
|---|---|
Price To Sales (TTM) | 0.51 |
Price To Book (MRQ) | 1.41 |
Price To Cash Flow (TTM) | 7.28 |
Total Debt To Equity (MRQ) | 376.93 |
LT Debt To Equity (MRQ) | 261.85 |
Return on Investment (TTM) | -2.12 |
Return on Equity (TTM) | -1.40 |
* Says its shareholder, NIPRO Corp, will sell 5 percent stake(1.1 million shares) in the company to Nagase & Co Ltd , at the price of 350 yen per share, for 384.5 million yen in total, on March 30
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.